Meningococcal Disease Completed Phase 3 Trials for Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (DB10061)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02106390Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy InfantsPrevention